0002027042-24-000004.txt : 20240807 0002027042-24-000004.hdr.sgml : 20240807 20240807141335 ACCESSION NUMBER: 0002027042-24-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 EFFECTIVENESS DATE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kate Therapeutics Inc. CENTRAL INDEX KEY: 0002032702 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-520826 FILM NUMBER: 241182934 BUSINESS ADDRESS: STREET 1: 10675 SORRENTO VALLEY ROAD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 619-614-3609 MAIL ADDRESS: STREET 1: 10675 SORRENTO VALLEY ROAD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Kate Therapeutics, Inc. DATE OF NAME CHANGE: 20240805 D 1 primary_doc.xml X0708 D LIVE 0002032702 Kate Therapeutics Inc. 10675 SORRENTO VALLEY ROAD, SUITE 150 SAN DIEGO CA CALIFORNIA 92121 619-614-3609 DELAWARE Kate Therapeutics, Inc. Corporation true 2020 Kevin Forrest, Ph.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Director Clare Ozawa, Ph.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92121 Director Beth Seidenberg, M.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2024-05-17 false true false 0 23363910 21775022 1588888 Total Amount Sold includes amounts paid in both cash and pursuant to conversion of indebtedness. false 8 0 0 0 false Kate Therapeutics Inc. /s/ Kevin Forrest Kevin Forrest, Ph.D. Chief Executive Officer 2024-08-07